Chlorthalidone recalls

Chlorthalidone products have been recalled 5 times, most recently on 23 Sep 2026. The recalling company is usually Inventia Healthcare. The most common reason is potency & assay.

Total recalls5since 2022

Last 12 months2reported

Class I00% of total

Ongoing3latest 23 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 1 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 1 0 0Aug 1 0

Severity split

Class I 0 0%Class II 5 100%Class III 0 0%

Why chlorthalidone is recalled

Companies

Product types

Blood Pressure Medication5100%

By year

2026240%
2025120%
2024120%
2022120%

Ongoing chlorthalidone recalls

3 active

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg recalled by Inventia HealthcareChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
24 Jun 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg Unit Dose cards recalled by AvKAREChlorthalidone	AvKARE	Potency & Assay	Nationwide

All chlorthalidone recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg recalled by Inventia HealthcareChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
24 Jun 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg Unit Dose cards recalled by AvKAREChlorthalidone	AvKARE	Potency & Assay	Nationwide
3 Jan 2024Drug	CLASS II	Chlorthalidone Tablets, USP, 25MG recalled by Cardinal HealthcareChlorthalidone	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
23 Feb 2022Drug	CLASS II	Chlorthalidone Tablets USP 25 mg recalledChlorthalidone	SUN Pharmaceutical Industries	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.